Notícias Acumen Pharmaceuticals Inc - ABOS | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Acumen Pharmaceuticals Inc (ABOS)
Acumen Pharmaceuticals Inc (ABOS) Notícias

Acumen Pharmaceuticals Inc (ABOS)

1,75

-0,03

(-1,69%)

Fechado 30 Dezembro 6:00PM

Atrasado por 15 minutos

1,75

0,00

( 0,00% )

Pré-mercado: 6:54AM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Acumen Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Highlights

Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Acumen Pharmaceuticals to Participate in the UBS Global Healthcare Conference

Acumen Pharmaceuticals Appoints Dr. Amy Schacterle as Chief Regulatory Officer & Head of Quality

Acumen Pharmaceuticals to Report Third Quarter Results on Nov. 12, 2024

Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease Conference

Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference

Acumen Pharmaceuticals Extends Collaboration with Lonza to Add Drug Product Manufacturing of Sabirnetug for Early Alzheimer’s Disease

Acumen Pharmaceuticals to Host Virtual R&D Day on Oct. 2, 2024

Acumen Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investor Conference

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Acumen Pharmaceuticals

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições